FuzzyBot: Importing a new version from external source

2024-03-07T10:13:21Z

Importing a new version from external source

New page

From human clinical trials, it has become increasingly evident that a more effective focus of treatment is slowing, stopping and even partially reversing the atheroma growth process. There are several prospective epidemiologic studies including the [[Atherosclerosis Risk in Communities|Atherosclerosis Risk in Communities (ARIC) Study]] and the Cardiovascular Health Study (CHS), which have supported a direct correlation of [[Carotid]] [[Intima-media thickness]] (CIMT) with myocardial infarction and stroke risk in patients without cardiovascular disease history. The ARIC Study was conducted in 15,792 individuals between 5 and 65 years of age in four different regions of the US between 1987 and 1989. The baseline CIMT was measured and measurements were repeated at 4- to 7-year intervals by carotid B mode ultrasonography in this study. An increase in CIMT was correlated with an increased risk for CAD. The CHS was initiated in 1988, and the relationship of CIMT with risk of myocardial infarction and stroke was investigated in 4,476 subjects 65 years of age and below. At the end of approximately six years of follow-up, CIMT measurements were correlated with cardiovascular events.

Translations:Atheroma/32/en - Revision history

FuzzyBot: Importing a new version from external source